Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice

Sexually Transmitted Diseases

Volumn 37, Issue 9, 2010, Pages 579-584

  Vincent, Kathleen L ^a,b   Bell, Brent A ^b   Johnston, Rebecca K ^b   Stegall, Rachael ^a   Vargas, Gracie ^a,b   Tan, Alai ^c   Stanberry, Lawrence R ^d   Rosenthal, Susan L ^d   Milligan, Gregg N ^a,c   Motamedi, Massoud ^b,c   Bourne, Nigel ^a,c  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b Center for Biomedical Engineering   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; MICROBICIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG SAFETY; ENDOSCOPY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HISTOLOGY; INFLAMMATORY CELL; MOUSE; NONHUMAN; VAGINA; VAGINA EPITHELIUM; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BENZALKONIUM COMPOUNDS; COLPOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; MICE; TREATMENT OUTCOME; VAGINA;

EID: 77955899471     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181dac410     Document Type: Article

References (32)

1. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carra-guard for prevention of HIV infection in women in South Africa: A randomized, double-blind, placebo-controlled trial. Lancet 2008; 372:1977-1987.
2. Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis 2008; 8:685-697.
3. Van de Wijgert J, Shattock R. Vaginal microbicides: Moving ahead after an unexpected setback. AIDS 2007; 21:2369-2376.
4. Vincent KL, Bourne N, Bell BA, et al. High resolution imaging of epithelial injury in the sheep cervicovaginal tract: A promising model for testing safety of candidate microbicides. Sex Transm Dis 2009; 36:312-318.
5. D'Cruz OJ, Erbeck D, Uckun FM. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the non-irritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxic Pathol 2005; 33: 465-476.
6. Fichorova RN, Bajpai M, Chandra N, et al. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod 2004; 71:761-769.
7. Milligan GN, Dudley KL, Bourne N, et al. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides. Sex Transm Dis 2002; 29:597-605.
8. Bourne N, Stegall R, Montano R, et al. Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal HSV-2 infection. Antimicrob Agents Chemother 2005; 49:1181-1183.
9. Milligan GN, Young CG, Meadora MG, et al. Effects of candidate vaginally-applied microbicide compounds on innate immune cells. J Reprod Immunol 2005; 66:103-116.
10. Patton DL, Kidder GG, Sweeney YC, et al. Effects of nonoxy-nol-9 on vaginal microflora and chlamydial infection in a monkey model. Sex Transm Dis 1996; 23:461-464.
11. Schlievert PM, Stranberg KL, Brosnahan AJ, et al. Glycerol monolaurate does not alter Rhesus Macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrob Agents Chemother 2008; 52:4448-4454.
12. Cone RA, Hoen T, Wong X, et al. Vaginal microbicides: Detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis 2006; 6:90.
13. Galen BT, Martin AP, Hazrati E, et al. A comprehensive murine model to evaluate topical vaginal microbicides: Mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. J Infect Dis 2007; 195:1332-1339.
14. Vincent KL, Bell BA, Rosenthal SL, et al. Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: Potential for assessment of microbicide safety. Sex Transm Dis 2008; 35:269-275.
15. Vargas G, Shilagard T, Johnston R, et al. Use of high-resolution confocal imaging of vaginal epithelial microstructure to detect microbicide toxicity. J Infect Dis 2009; 199:1546-1552.
16. Mayer KH, Maslankowski LA, Gai F, et al. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS 2006; 20:543-551.
17. Williams DL, Newman DR, Ballagh SA, et al. Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Sex Transm Dis 2007; 34:977-984.
18. Ballagh SA, Brache V, Mauck C, et al. A phase I study of the functional performance, safety and acceptability of the BufferGel Duet. Contraception 2008; 77:130-137.
19. Schwartz JL, Kovalesky G, Lai J-J, et al. A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor. Sex Transm Dis 2008; 35:414-419.
20. Patton DL, Cosgrove Sweeney YT, Paul KJ. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model. Sex Transm Dis 2008; 35:889-897.
21. Scorpio DG, Ruben DS, Liao Z, et al. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies. J Med Primatol 2007; 37(suppl 1):65-73.
22. Patton DL, Ganzle Kidder G, Cosgrove Sweeney Y, et al. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol 1999; 180:1080-1087.
23. WHO/CONRAD. Manual for the standardization of colposcopy for the evaluation of vaginal products, Update 2004. Geneva, Switzerlandý: CONRAD/WHO, 2004.
24. Becker C, Fantinin MC, Wirtz S, et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 2005; 54:950-954.
25. Poonia B, Walter L, Dufour J, et al. Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol 2006; 190: 829-835.
26. Smith SM, Mefford M, Sodora D, et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004; 18:1637-1643.
27. Bourne N, Bernstein DI, Ireland J, et al. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis 1999; 180:203-205. (Pubitemid 29293937)
28. Bourne N, Stanberry LR, Kern ER, et al. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother 2000; 44:2471-2474.
29. Bourne N, Zanneveld LJ, Ward JA, et al. Poly(sodium 4-styrene sulfonate): Evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infection in mice. Clin Microbiol Infect 2002; 9:816-822.
30. Zacharopoulos VR, Phillips DM. Vaginal formulations of carra-geenan protect mice from herpes simplex virus infections. Clin Diagn Lab Immunol 1997; 4:465-468.
31. Su H, Caldwell HD. Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo model of Chlamydia genital tract infection. Infect Immun 1998; 66: 1258-1260.
32. Zeitlin L, Whaley KJ, Hegarty TA, et al. Tests of vaginal micro-bicides in the mouse genital herpes model. Contraception 1997; 56:329-335.